NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
Quick Stats
Jan 30, 202642.5
AI Score
HOLD1.17
Volume Ratio
Mar 19, 2026
Next Earnings
11
+ve Days (30d)
17
-ve Days (30d)
NCNA Stock Summary
Last updated Jan 30, 2026
NCNA is currently trading at $2.51, positioned below its 200-day moving average of $13.62, suggesting bearish momentum. The stock has a 52-week range of $0.0313 to $268.
Technical Analysis: The 50-day moving average stands at $3.57, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 23.084, suggesting the stock is oversold and potentially undervalued.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.301, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates NCNA at 42.5/100 with a HOLD recommendation.
NCNA (NuCana plc American Depositary Share) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 23.084 |
| CMF (20) | -0.301 |
| ROC (10) | -24.85 |
| ADX (14) | 14.934 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.227 |
| AROONOSC (14) | -85.714 |
| WILLAMS %R (14) | -97.015 |
| MFI (14) | 55.079 |
NCNA Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NCNA Price vs Max Options Open Interest
NCNA Max Change In Options Open Interest
NCNA Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NCNA Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NCNA Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NCNA Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NuCana plc American Depositary Share is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
NCNA Moving Averages Analysis
NCNA (NuCana plc American Depositary Share) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 3.04 |
| 20 | 3.28 |
| 30 | 3.34 |
| 50 | 3.57 |
| 100 | 3.94 |
| 200 | 13.62 |
NCNA Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | 0.0071 |
| Market Cap ($) | 5.6 million |
| Earnings/Share ($) | 414.7 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | -0.052 |
| WallStreet Target Price ($) | 104 |
| Most Recent Quarter |